Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367644-23-000208
Filing Date
2023-12-11
Accepted
2023-12-11 07:24:51
Documents
105
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ebs-20230930.htm   iXBRL 10-Q 2627372
2 EX-10.1 emergentbiosolutionsincind.htm EX-10.1 118266
3 EX-10.2 formofletteragreementdated.htm EX-10.2 35491
4 EX-31.1 a311-millercert093023.htm EX-31.1 8500
5 EX-31.2 a312-lindhalcert093023.htm EX-31.2 8564
6 EX-32.1 a321-millercert093023.htm EX-32.1 3550
7 EX-32.2 a322-lindhalcert093023.htm EX-32.2 3400
13 ebs-20230930_g1.jpg GRAPHIC 75656
14 image.jpg GRAPHIC 7369
  Complete submission text file 0001367644-23-000208.txt   13869171

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20230930.xsd EX-101.SCH 57887
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ebs-20230930_cal.xml EX-101.CAL 78065
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ebs-20230930_def.xml EX-101.DEF 450855
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20230930_lab.xml EX-101.LAB 798970
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20230930_pre.xml EX-101.PRE 668444
99 EXTRACTED XBRL INSTANCE DOCUMENT ebs-20230930_htm.xml XML 2741999
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33137 | Film No.: 231476907
SIC: 2834 Pharmaceutical Preparations